Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Abbott Laboratories
(NY:
ABT
)
109.21
+1.01 (+0.93%)
Streaming Delayed Price
Updated: 3:29 PM EST, Feb 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
9,918,306
Open
109.16
Bid (Size)
109.21 (200)
Ask (Size)
109.23 (600)
Prev. Close
108.20
Today's Range
107.91 - 110.14
52wk Range
105.27 - 141.23
Shares Outstanding
1,750,942,289
Dividend Yield
2.31%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
AbbVie’s Prognosis: The February Dip Looks Like a Buy Signal
↗
Today 12:32 EST
Via
MarketBeat
Navigating the MedTech Correction: A Deep-Dive into Boston Scientific (NYSE: BSX)
Today 9:41 EST
February 5, 2026 The medical technology landscape experienced a seismic shift this week as one of its long-standing titans, Boston Scientific (NYSE: BSX), faced a "valuation reset" that has left...
Via
Finterra
Topics
Product Recall
World Trade
Performance
YTD
-12.1%
-12.1%
1 Month
-13.6%
-13.6%
3 Month
-12.3%
-12.3%
6 Month
-16.6%
-16.6%
1 Year
-15.4%
-15.4%
More News
Read More
2 Healthcare Dividend Stocks That are Just What the Doctor Ordered
↗
February 03, 2026
Via
The Motley Fool
Topics
Intellectual Property
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Northfield Bancorp Inc. (Nasdaq - NFBK), Coterra Energy Inc. (NYSE - CTRA), Exact Sciences Corporation (Nasdaq – EXAS), Semrush Holdings, Inc. (NYSE – SEMR)
February 03, 2026
From
Brodsky & Smith LLC
Via
GlobeNewswire
The Best Dividend King to Buy With $150
↗
February 02, 2026
Via
The Motley Fool
Boston Scientific’s $14.5 Billion Stroke of Genius: Consolidation Heats Up in the Medtech Arms Race
February 02, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Looking for Passive Income in 2026? 3 Dividend Kings to Buy Hand Over Fist
↗
January 31, 2026
Via
The Motley Fool
5 Insightful Analyst Questions From Abbott Laboratories’s Q4 Earnings Call
January 29, 2026
Via
StockStory
Topics
Earnings
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.
↗
January 23, 2026
Via
Chartmill
3 Reasons to Buy This Dividend King After Its Steep Sell-Off
↗
January 26, 2026
Via
The Motley Fool
Topics
Earnings
The Best Dividend Stocks to Buy and Hold Forever
↗
January 26, 2026
Via
The Motley Fool
Topics
Intellectual Property
Is Abbott’s January Pullback a Good Time to Buy?
↗
January 24, 2026
Via
MarketBeat
Which stocks are moving after the closing bell on Friday?
↗
January 23, 2026
Via
Chartmill
Greenland Truces and Intel’s Earnings Bruises: Wall Street’s Identity Crisis
↗
January 23, 2026
Via
Chartmill
Which S&P500 stocks have an unusual volume on Thursday?
↗
January 22, 2026
Via
Chartmill
Johnson & Johnson 2026 Outlook: Chasing the $100 Billion Milestone Amidst Legal and Patent Hurdles
January 23, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Bankruptcy
Economy
The Software Surge: How 2024’s $25.7 Billion M&A Explosion in Diagnostics Redefined Healthcare
January 23, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
ABT Q4 Deep Dive: Nutrition Weakness and Innovation Shape 2026 Outlook
January 23, 2026
Via
StockStory
Abbott Laboratories Shares Plunge 10% Following Q4 Revenue Miss and Diagnostics Weakness
January 22, 2026
Via
MarketMinute
Topics
Economy
These S&P500 stocks are moving in today's session
↗
January 22, 2026
Via
Chartmill
Why Abbott Laboratories (ABT) Shares Are Sliding Today
January 22, 2026
Via
StockStory
Top S&P500 movers in Thursday's session
↗
January 22, 2026
Via
Chartmill
Abbott (ABT) Q4 2025 Earnings Call Transcript
↗
January 22, 2026
Via
The Motley Fool
Topics
Earnings
World Trade
Abbott Shares Slump as Revenue Miss and Exact Sciences Acquisition Jitters Overshadow Earnings Beat
January 22, 2026
Via
MarketMinute
Topics
Earnings
Economy
What's going on in today's session: S&P500 gap up and gap down stocks
↗
January 22, 2026
Via
Chartmill
Frequently Asked Questions
Is Abbott Laboratories publicly traded?
Yes, Abbott Laboratories is publicly traded.
What exchange does Abbott Laboratories trade on?
Abbott Laboratories trades on the New York Stock Exchange
What is the ticker symbol for Abbott Laboratories?
The ticker symbol for Abbott Laboratories is ABT on the New York Stock Exchange
What is the current price of Abbott Laboratories?
The current price of Abbott Laboratories is 109.21
When was Abbott Laboratories last traded?
The last trade of Abbott Laboratories was at 02/05/26 03:29 PM ET
What is the market capitalization of Abbott Laboratories?
The market capitalization of Abbott Laboratories is 191.22B
How many shares of Abbott Laboratories are outstanding?
Abbott Laboratories has 191B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.